The Woodlands, TX, United States of America

Ganapathi R Revankar


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1992-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ganapathi R Revankar: Innovator in Antiviral Compounds

Introduction

Ganapathi R Revankar is a notable inventor based in The Woodlands, TX (US). He has made significant contributions to the field of antiviral research, holding a total of 3 patents. His work focuses on developing guanine analogs that serve as potential treatments for viral diseases.

Latest Patents

Revankar's latest patents include a series of antiviral guanine analogs. These compounds are designed to act as virus inhibitors and antiviral agents in the treatment of viral diseases. The basic structures of these guanine analogs include various functional groups that enhance their efficacy. The compounds can be formulated with a physiological carrier and may be used alone or in combination with other therapeutic agents, such as acyclovir or ganciclovir, to treat conditions resulting from viral infections.

Career Highlights

Throughout his career, Ganapathi R Revankar has worked with various organizations, including Aronex Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to focus on innovative solutions for combating viral infections.

Collaborations

Revankar has collaborated with notable professionals in his field, including Arthur F Lewis and Birendra K Bhattacharya. These collaborations have contributed to the advancement of his research and the development of his patented compounds.

Conclusion

Ganapathi R Revankar's work in antiviral guanine analogs showcases his commitment to innovation in the pharmaceutical industry. His contributions are vital in the ongoing fight against viral diseases, and his patents reflect his expertise and dedication to improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…